The IPO Buzz: CG Oncology Prices Upsized IPO at $19 – $1 Above Range
Twice: Bladder cancer biotech CG Oncology (CGON) upsized its IPO for the second time this week – by pricing 20.0 million shares at $19.00 – $1.00 above the top of its range – to raise $380.0 million on Wednesday night (Jan. 24, 2024). This is the first biotech IPO of the year – and the […]
January 24, 2024 Read More